Abstract
Bleomycin, vincristine, and mitomycin C (BOM) as second-line treatment after failure of cis-platinum-based combination chemotherapy for recurrent cervical cancer
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have